Health Care • Industrial Specialties
$31.10 ▲ +1.14
(+3.81%)
MKT CAP: $1.33B • VOL: 433.1K
52W L $24 52W H $49
CDRE // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $610.3M | $567.6M | $482.5M |
| YoY Revenue Growth % | +7.5% | +17.6% | — |
| Gross Profit | $259.6M | $233.5M | — |
| Gross Margin % | 42.5% | 41.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $67.4M | $66.8M | $56.5M |
| Operating Margin % | 11.0% | 11.8% | 11.7% |
| Net Income (GAAP) | $44.1M | $36.1M | $38.6M |
| EBITDA (Normalized) | $72.8M | $71.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $63.7M | $31.8M | $73.2M |
| Capital Expenditures (CapEx) | $6.9M | $5.7M | — |
| Free Cash Flow (FCF) | $56.8M | $26.1M | $73.2M |
| FCF Margin % | 9.3% | 4.6% | 15.2% |
| Return on Invested Capital (ROIC %) | 11.0% | 13.2% | — |
| Cash & Short-Term Equivalents | $122.9M | $124.9M | — |
| Total Debt (Short + Long Term) | $291.0M | $211.8M | — |
| Total Stockholders' Equity | $317.8M | $311.5M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CDRE.